Third-generation CAR T Cells within the Heidelberg CAR Trial 1 (HD-CAR-1) Display an Excellent Safety Profile and Might Improve Persistence of CAR T Cells

被引：0
|
作者：
Schubert, Maria-Luisa [1 ]
Schmitt, Anita [1 ]
Hueckelhoven-Krauss, Angela [1 ]
Neuber, Brigitte [1 ]
Kunz, Alexander [1 ]
Wang, Lei [1 ]
Michels, Birgit [1 ]
Gern, Ulrike [1 ]
Sellner, Leopold [1 ]
Hofmann, Susanne [1 ]
Pavel, Petra [2 ]
Ho, Anthony [1 ]
Mueller-Tidow, Carsten [1 ]
Dreger, Peter [1 ]
Schmitt, Michael [1 ]
机构：
[1] Univ Heidelberg Hosp, Heidelberg, Germany
[2] German Red Cross Blood Serv Baden Wuerttemberg He, Heidelberg, Germany
来源：
BONE MARROW TRANSPLANTATION | 2020年 / 55卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
O036
引用
收藏
页码：46 / 47
页数：2
相关论文
共 50 条
  • [21] Treatment of adult ALL patients with third-generation CD19-directed CAR T cells: results of a pivotal trial
    Schubert, Maria-Luisa
    Schmitt, Anita
    Hueckelhoven-Krauss, Angela
    Neuber, Brigitte
    Kunz, Alexander
    Waldhoff, Philip
    Vonficht, Dominik
    Yousefian, Schayan
    Jopp-Saile, Lea
    Wang, Lei
    Korell, Felix
    Keib, Anna
    Michels, Birgit
    Haas, Dominik
    Sauer, Tim
    Derigs, Patrick
    Kulozik, Andreas
    Kunz, Joachim
    Pavel, Petra
    Laier, Sascha
    Wuchter, Patrick
    Schmier, Johann
    Bug, Gesine
    Lang, Fabian
    Goekbuget, Nicola
    Casper, Jochen
    Goerner, Martin
    Finke, Juergen
    Neubauer, Andreas
    Ringhoffer, Mark
    Wolleschak, Denise
    Brueggemann, Monika
    Haas, Simon
    Ho, Anthony D.
    Mueller-Tidow, Carsten
    Dreger, Peter
    Schmitt, Michael
    [J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2023, 16 (01)
  • [22] Treatment of adult ALL patients with third-generation CD19-directed CAR T cells: results of a pivotal trial
    Maria-Luisa Schubert
    Anita Schmitt
    Angela Hückelhoven-Krauss
    Brigitte Neuber
    Alexander Kunz
    Philip Waldhoff
    Dominik Vonficht
    Schayan Yousefian
    Lea Jopp-Saile
    Lei Wang
    Felix Korell
    Anna Keib
    Birgit Michels
    Dominik Haas
    Tim Sauer
    Patrick Derigs
    Andreas Kulozik
    Joachim Kunz
    Petra Pavel
    Sascha Laier
    Patrick Wuchter
    Johann Schmier
    Gesine Bug
    Fabian Lang
    Nicola Gökbuget
    Jochen Casper
    Martin Görner
    Jürgen Finke
    Andreas Neubauer
    Mark Ringhoffer
    Denise Wolleschak
    Monika Brüggemann
    Simon Haas
    Anthony D. Ho
    Carsten Müller-Tidow
    Peter Dreger
    Michael Schmitt
    [J]. Journal of Hematology & Oncology, 16
  • [23] Generation of universal CAR T cells with a memory phenotype: safety and efficacy studies
    Pavlovic, K.
    Carmona, M. D.
    Maldonado, N.
    Cortijo, M.
    Molina, F. J.
    Justicia, P.
    Tristan, M.
    Corsi, G. I.
    Seemann, S. E.
    Gorodkin, J.
    Martin, F.
    Herrera, I. C.
    Benabdellah, K.
    [J]. HUMAN GENE THERAPY, 2022, 33 (23-24) : A131 - A132
  • [24] PD-1 blockade modulates chimeric antigen receptor (CAR)-modified T cells: refueling the CAR
    Chong, Elise A.
    Melenhorst, J. Joseph
    Lacey, Simon F.
    Ambrose, David E.
    Gonzalez, Vanessa
    Levine, Bruce L.
    June, Carl H.
    Schuster, Stephen J.
    [J]. BLOOD, 2017, 129 (08) : 1039 - 1041
  • [25] Ferroptosis Inhibition Generates TCF-1+CAR-T Cells with Enhanced Persistence and Cytotoxicity
    Harada, Shinpei
    Hashimoto, Daigo
    Saito, Yumika
    Miyajima, Toru
    Li, Wenyu
    Senjo, Hajime
    Zhang, Zixuan
    Kikuchi, Ryo
    Chiba, Masahiro
    Ohigashi, Hiroyuki
    Ara, Takahide
    Nakagawa, Masao
    Teshima, Takanori
    [J]. BLOOD, 2023, 142
  • [26] Novel CS1 CAR-T Cells and Bispecific CS1-BCMA CAR-T Cells Effectively Target Multiple Myeloma
    Golubovskaya, Vita
    Zhou, Hua
    Li, Feng
    Berahovich, Robert
    Sun, Jinying
    Valentine, Michael
    Xu, Shirley
    Harto, Hizkia
    Sienkiewicz, John
    Huang, Yanwei
    Wu, Lijun
    [J]. BIOMEDICINES, 2021, 9 (10)
  • [27] Current strategies to improve the safety of chimeric antigen receptor (CAR) modified T cells
    Yang, Qi-Yu
    Yang, Jia-dan
    Wang, Yong-Sheng
    [J]. IMMUNOLOGY LETTERS, 2017, 190 : 201 - 205
  • [28] Third-generation anti-CD19 CAR T cells for relapsed/refractory chronic lymphocytic leukemia: a phase 1/2 study
    Derigs, Patrick
    Schubert, Maria-Luisa
    Dreger, Peter
    Schmitt, Anita
    Yousefian, Schayan
    Haas, Simon
    Roethemeier, Caroline
    Neuber, Brigitte
    Hueckelhoven-Krauss, Angela
    Brueggemann, Monika
    Bernhard, Helga
    Kobbe, Guido
    Lindemann, Albrecht
    Rummel, Mathias
    Michels, Birgit
    Korell, Felix
    Ho, Anthony D.
    Mueller-Tidow, Carsten
    Schmitt, Michael
    [J]. LEUKEMIA, 2024,
  • [29] Reshape of CAR-T cells by overexpression of TCF-1
    Yao, H.
    Wang, L.
    Ding, Y.
    Wang, S.
    Chen, Q.
    Han, H.
    Lin, M.
    Sauer, T.
    Jiang, G.
    Neuber, B.
    Schibert, M. -L.
    Eckstein, V.
    Mueller-Tidow, C.
    Schmitt, A.
    Schmitt, M.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 302 - 302
  • [30] The persistence and antitumor efficacy of CAR-T cells are modulated by tonic signaling within the CDR
    Zhou, Jincai
    Shi, Feifei
    Luo, Xinran
    Lei, Bixia
    Shi, Zhongjun
    Huang, Chenyu
    Zhang, Yuting
    Li, Xiaopei
    Wang, Huajing
    Li, Xian -Yang
    He, Xiaowen
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 126
12345